Neurology Minute podcast

A Path to Preventing Cognitive Impairment Due to Alzheimer's Disease

0:00
2:02
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Dr. Greg Cooper and Dr. Eric Reiman discuss emerging antibody therapies for preclinical Alzheimer's disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.

Show citation: 

Reiman EM, Alexander RC, Langbaum JB, et al. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol. 2026;25(3):268-278. doi:10.1016/S1474-4422(25)00483-1 

Altri episodi di "Neurology Minute"